Quick Answer
GLAUKOS Corp reported Research And Development Expense of $49.68 million for the year ending 2018.
- GLAUKOS Corp showed an increase of +27.7% in Research And Development Expense from 2017 to 2018.
- This data is from GLAUKOS Corp's annual report (Form 10-K), filed with the SEC on February 28, 2019.
- XBRL data for this metric is available from 2013 to 2018 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $4.38 million | Q2 2014: $4.42 million | Q3 2014: $5.09 million | Q4 2014: $5.31 million | Q1 2015: $5.24 million | Q2 2015: $7.34 million | Q3 2015: $6.17 million | Q4 2015: $6.30 million | Q1 2016: $7.06 million | Q2 2016: $6.96 million | Q3 2016: $7.81 million | Q4 2016: $7.40 million | Q1 2017: $8.94 million | Q2 2017: $9.63 million | Q3 2017: $9.81 million | Q4 2017: $10.53 million | Q1 2018: $10.91 million | Q2 2018: $12.61 million | Q3 2018: $13.20 million | Q4 2018: $12.96 million | Q1 2019: $13.93 million | Q1 2021: $21.22 million | Q1 2022: $26.88 million.
- Over the full 6 years of available data (2013 to 2018), GLAUKOS Corp's Research And Development Expense has grown by 220.3%.
- Historical annual values: Fiscal year 2018: $49.68 million | Fiscal year 2017: $38.91 million | Fiscal year 2016: $29.22 million | Fiscal year 2015: $25.05 million | Fiscal year 2014: $19.21 million | Fiscal year 2013: $15.51 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: